×
Clinical Outcomes of Ultra-Hypofractionated MR-Guided Adaptive SABR (SMART) for Localized Pancreatic Cancer: EMERALD Phase 1 Trial (ISRCTN10557832)
Moreno-Olmedo E., Massa MS., Mukherjee S., PDF S.
DOI
10.2139/ssrn.6841448
Type
Preprint
Publication Date
2026-01-01T00:00:00+00:00